<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">146</article-id>
<title-group><article-title>An Innovative Approach of Escalating Maternal Fetal Outcomes in Pregnancies associated with Obesity: Overcoming Deficiency of Resolvins associated with Obesity: A Systematic Review</article-title></title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Kaur</surname><given-names>Kulvinder Kochar</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Allahbadia</surname><given-names>Gautam Nand K</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Singh</surname><given-names>Mandeep</given-names></name><xref ref-type="aff" rid="aff2"/></contrib>
<aff id="aff1"><label>1</label>Scientific Director, Dr.Kulvinder Kaur Centre for Human Reproduction, GTB Nagar, Jalandhar, Punjab, India</aff>
<aff id="aff2"><label>2</label>Consultant Neurologist, Swami Satyanand Hospital, Near Nawi Kachehri, Baradri, Ladowali road, Jalandhar, Punjab, India</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><year>2022</year></pub-date>
<volume>3</volume>
<issue>4</issue>
<fpage>03</fpage>
<lpage>13</lpage>
<history>
<date date-type="received"><day>25</day><month>09</month><year>2022</year></date>
<date date-type="accepted"><day>11</day><month>10</month><year>2022</year></date>
</history>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/146/an-innovative-approach-of-escalating-maternal-fetal-outcomes-in-pregnancies-associated-with-obesity"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/146/download"/>
<abstract><p>In view of pregnancy possessing the properties of mild however considerable significant inflammatory action under physiological circumstances, ongetting complicated byobesity the chances of a continuous inflammatory state enhances with subsequent numerous consequences with additional complications correlated with acute inflammation. Regarding this the part of resolvins alias Specialized proresolving mediators (SPM) obtained from Omega3 essentiafatty acids might bekey. Actually differential generation of multiple high risk situations is correlated with child birth along with neonatal health, the association amongst, maternal omega 3 fatty acids consumption as well as resolvins amounts in maternal blood along with placental level in addition to greater amounts observed in breast milk at the time of first mth of breast feeding, represent certain of the maximum significant cornerstone concerning these autacoids. In addition to that escalation of scientific corroboration proves the absence of SPM at the immuno metabolic tissue level regarding obesity. Moreover, the obesity correlated absence of SPMs apparently is the deciding factor even regarding the recent Coronavirus disease (COVID19) pandemic since apparently it is amongst the reasons correlated with greater complications in addition to the negative results of SARS-CoV2 infection. The utilization of metabolomics in this speciality has been clarified, with the information that via metabolome it is feasible to watch the multiple along with complicated crosstalk amongst mother, placenta along with fetus, regarding the Identification of particular biomarker regarding the anticipation, diagnosis besides supervision of different obstetric situations. Nevertheless, greater evaluation is required for part of resolving as biomarkers of Maternal –Fetal outcomes besides generation of enough values regarding integration in pregnant women with Omega3 fatty acids or with greater derivatives for ensuring ideal SPM generation under high risk situations.


 </p></abstract>
<kwd-group kwd-group-type="author"><kwd>resolvins</kwd><kwd>obesity</kwd><kwd>Omega essential fatty acids</kwd><kwd>breast milk</kwd><kwd>maternal-fetal outcomes</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Poon LC, McIntyre HD, Hyett JA, da Fonseca EB, Hod M. FIGO Pregnancy and NCD Committee. The first trimester of Pregnancy-a WINDOW of opportunity of pregnancy complications and future life. Diabetes Res Clin Pract. 2018; 145:20-30.</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>Parrettini S, Carroli A, Torlone E. Nutrition and metabolic adaptations in physiological and complicated pregnancy: focus on obesity and Gestational Diabetes. Front Endocrinol. 2020; 11:6111929.</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Chen C, Xu X, Yan Y. Estimated global over weight and obesity burden in pregnant women based on panel data model. PLoS. ONE2018:13:e0202183.</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Robinson E, Boyland E, Chrisholm A, Harrold J, Maloney NG, Marty L, et al. Obesity, eating behaviour and physical activity during Covid19 lockdown: a study of UK adults. Appetite. 2021; 156:104853.</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Ghesquiere L, Garabedian C, Drumez E, Lemaltre M, Cazaubiel M, Bengler C, et al. Effects of Covid19 pandemic lockdown on Gestational Diabetes mellitus: a retrospective study. Diabetes Metab. 2021; 47:101201.</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>Zhang J, Zhang Y, Huo S, Ma Y, Ke Y, Wang P, et al. Emotional eating in pregnant women during COVID19 pandemic and its association with dietary intake and gestational weight gain. Nutrients. 2020; 12:2250.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Elliot E, Hanson CK, Anderse-Berry AL, Nordgren TM. The role of specialized pro resolving mediators in maternal fetal health. Prostaglandins Leukot Essent Fat Acids. 2017; 126:98-104.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Hulzinga GP, Singer BH, Singer K. The collision of meta inflammation and SARS-CoV2 pandemic infection. Endocrinology. 2020; 161:bqaa154.</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Dalamaga M, Christodoulatos GS, Karampela I, Vallianou N, Apovian CM. Understanding the co-epidemic of obesity and Covid19: current evidence with previous epidemics, mechanisms and preventive and therapeutic perspectives. Curr Obese Rep. 2021; 10:214-43.</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Tognocchi M, Conte M, Testai L, Martucci M, Serra A, Calderone V, et al. Supplementation of enriched polyunsaturated fatty acids and CLA cheese on high fat diet: Effects on lipids metabolism and fat profile. Foods. 2022; 11:398.</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>Strunk T, Inder T, Wang X, Brugner D, Mallard C, Levy O. Infection induced inflammation and cerebral injury in preterm infants. Lancet Infect Dis. 2014; 14:751-62.</mixed-citation></ref>
<ref id="R12"><label>12</label><mixed-citation>Koletzko B, Boey CC, Campoy C, Carlson SE, Chang N, Guillermo Tuazon M, et al. Current information and Asian perspectives on long chain polyunsaturated fatty acids in pregnancy, lactation and infancy: systematic International Journal of Medical and All Body Health Research www.allmedicaljournal.com review and Practice recommendations from an early nutrition academy workshop. Ann Nutr Metab. 2014; 65:49-80.</mixed-citation></ref>
<ref id="R13"><label>13</label><mixed-citation>Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Rev Immunol. 2005; 6:1191-7.</mixed-citation></ref>
<ref id="R14"><label>14</label><mixed-citation>Willoughby DA, Moore AR, Colville-Nash PR, Gillroy D. Resolution of inflammation. Int J Immunopharmacol. 2000; 22:1131-5.</mixed-citation></ref>
<ref id="R15"><label>15</label><mixed-citation>Han J, Ulevitch RJ. Limiting inflammatory responses during activation of innate immunity. Nat Rev Immunol. 2005; 6:1198-205.</mixed-citation></ref>
<ref id="R16"><label>16</label><mixed-citation>Tracy KJ. Physiology and Immunology of cholinergic anti inflammatory pathway. J Clin Investig. 2007; 117:289-96.</mixed-citation></ref>
<ref id="R17"><label>17</label><mixed-citation>Kulvinder Kochar Kaur, Allahbadia GN, Singh M. A Review of Nutrient Metabolism in Obesity with Special Emphasis on Fatty Acid Metabolism. BAOJ Food Sci&amp; Tec, 1, 001.</mixed-citation></ref>
<ref id="R18"><label>18</label><mixed-citation>Kulvinder Kochar Kaur, Allahbadia GN, Singh M. Synthesis and functional significance of Poly Unsaturated fatty acids (PUFA’s) in body. Acta Scientific Nutritional Health. 2018; 2(4):43-50.</mixed-citation></ref>
<ref id="R19"><label>19</label><mixed-citation>Kulvinder Kochar Kaur, Allahbadia GN, Singh M. The association of dietary fatty acids and gut microbiota alterations in the development of neuropsychiatric diseases: A systematic review. Obes Res Open J. 2020; 7(1):19-45. Doi: 10.17140/OROJ-7-143.</mixed-citation></ref>
<ref id="R20"><label>20</label><mixed-citation>Chiang N, Serhan CN. Specialized pro resolving mediators networks: an update on production and actions. Essays Biochem. 2020; 64:443-62.</mixed-citation></ref>
<ref id="R21"><label>21</label><mixed-citation>Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Investig. 2011; 121:2111-17.</mixed-citation></ref>
<ref id="R22"><label>22</label><mixed-citation>Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011; 29:415-45.</mixed-citation></ref>
<ref id="R23"><label>23</label><mixed-citation>Spite M, Claria J, Serhan CN. Resolvins, specialized proresolving mediators, and their potentialroles in metabolic diseases. Cell Metab. 2014; 19:21-36.</mixed-citation></ref>
<ref id="R24"><label>24</label><mixed-citation>Chawla A, Nguyen KD, Goh YP. Macrophage Mediated inflammation in metabolic diseases. Nat Rev Immunol. 2011; 11:85-97.</mixed-citation></ref>
<ref id="R25"><label>25</label><mixed-citation>Evan’s AC, Papachristou GI, Whitcomb DC. Obesity and the risk of severe acute Pancreatitis. Minerva Gastroenterol Dietol. 2010; 56:169-79.</mixed-citation></ref>
<ref id="R26"><label>26</label><mixed-citation>Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, Bjorbaek C, et al. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron. 1999; 23:775-86.</mixed-citation></ref>
<ref id="R27"><label>27</label><mixed-citation>Serhan CN. Resolution phase of inflammation: novel anti-inflammatory and pro resolving mediators and pathways. Annu Rev Immunol. 2007; 25:101-37.</mixed-citation></ref>
<ref id="R28"><label>28</label><mixed-citation>Serhan CN, Yacoubian S, Yang R. Anti inflammatory and proresolving mediators. Annu Rev Pathol 2008; 3:279-312.</mixed-citation></ref>
<ref id="R29"><label>29</label><mixed-citation>Bannenberg G, Serhan CN. Specialized pro resolving mediators in the inflammatory responses. Biochim Biophys Acta. 2010; 1801:1260 73.</mixed-citation></ref>
<ref id="R30"><label>30</label><mixed-citation>Mozurkewicz EL, Greenwood M, Clinton C, Berman D, Romero V, Djuric Z, et al. Pathway markers for proresolving lipids mediators in maternal and cord blood: a secondaryanalysis of mothers, Omega3 along with Mental Health study. Front Pharmacol. 2016; 7:274.</mixed-citation></ref>
<ref id="R31"><label>31</label><mixed-citation>Videla LA, Vargas R, Valenzuela R, Munoz P, Corbari A, Hernandez-Rodas MC. Combined administration of docosahexaenoic acid and the thyroid hormone synergistically rat liver cells of resolvins RvD1 and RvD2. Prostaglandins Leukot Essent Fat Acids. 2019; 140:42-6.</mixed-citation></ref>
<ref id="R32"><label>32</label><mixed-citation>Li C, Wu X, Liu S, Shen D, Zhu J, Liu K. Role of Resolvins in the inflammatory Resolution of neurological diseases. Front Pharmacol. 2020; 11:612</mixed-citation></ref>
<ref id="R33"><label>33</label><mixed-citation>Ostermann AL, West AL, Schoenfeld K, Browning LM, Walker CC, Jebb SA, et al. Plasma oxilipins respond to a linear dose response manner with increased intake of EPA and DHA: results from a randomized controlled Clinical trial in healthy humans. Am J Clin Nutr. 2019; 109:1251-63.</mixed-citation></ref>
<ref id="R34"><label>34</label><mixed-citation>Isobe Y, Arita M, Matsueda S, Iwamoto R, Fujihara T, Nakahashi H, et al. Identification and structure determination of novel anti inflammatory mediator resolvin E3,17,18 di hydroxy eicosapentaenoic acid. JBiol Chem. 2012; 287:10525-34.</mixed-citation></ref>
<ref id="R35"><label>35</label><mixed-citation>Bosco A, Dessi A, Zanza C, Pintus R, Fanos V. Resolvin‘s Obesity driven deficiency: the implications for Maternal Fetal health. Nutrients. 2022; 14:1662.</mixed-citation></ref>
<ref id="R36"><label>36</label><mixed-citation>Valdes AM, Ravipatti S, Menni C, Abishek A, Metrustry A, Harris J, et al. Association of the resolvin precursors 17HDHA butnot D or E series resolvins with heat pain sensitivity and osteoarthritis pain in humans. Sci Rep. 2017; 7:10748.</mixed-citation></ref>
<ref id="R37"><label>37</label><mixed-citation>Mas E, Croft KD, Zahra P, Barden A, Mori TA. Resolvins D1, D2 and other mediators of self-limited Resolution of inflammation in human blood following n-3 fatty acids Supplementation. Clin Chem 2012; 58:1476-84.</mixed-citation></ref>
<ref id="R38"><label>38</label><mixed-citation>Keelan JA, Mas E, D’Vaz N, D Unstan JA, Li S, Barden AE, et al. Effects of maternal n-3 fatty acids Supplementationon placental cytokines, pro resolving lipid mediators and their precursors. Reproduction. 2015; 149:171-8.</mixed-citation></ref>
<ref id="R39"><label>39</label><mixed-citation>Jones ML, Mark PJ, Keelan JA, Barden A, Mas E, Mori TA, et al. Maternal dietary Omega3 fatty acids intake increases Resolvins and protectin levels in rat placeta. J Lipid Res. 2013; 54:2247-54.</mixed-citation></ref>
<ref id="R40"><label>40</label><mixed-citation>Rey C, Nadjar A, Buaud B, Vaysee C, Abert A, Pallet V, et al. Resolvins D1, and E1 promote Resolution of inflammation in microglial cells in vitro. Brain Bhav Immun. 2016; 55:249-59.</mixed-citation></ref>
<ref id="R41"><label>41</label><mixed-citation>Salas- Hernandez A, Espinoza Perez C, Vivar R, Espitia -Corredor J, Lillo J, Parra Flores P, et al. Resolvins D1, and E1 promote promote resolution of inflammation in rat cardiac fibroblast in vitro. Mol BiolRep. 2021; 48:57-66.</mixed-citation></ref>
<ref id="R42"><label>42</label><mixed-citation>Weiss GA, Troxler H, Klinke G, Roger G, Braegger C, Hersberger M. High levels of antiinflammatory and proresolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. Lipids Health Dis. 2013; 12:89.</mixed-citation></ref>
<ref id="R43"><label>43</label><mixed-citation>Armardottir H, Orr SK, Dalli J, Serhan CN. Human milk proresolving mediators stimulate resolution of acute inflammation. Mucosal Immunol. 2016; 9:757-66.</mixed-citation></ref>
<ref id="R44"><label>44</label><mixed-citation>Yamashita A, Kawana K, Tomio K, Arita M, Taguchi A, Isobe Y, et al. Increased levels of Omega3 polyunsaturated fatty acids prevents pathological preterm birth. Sci. Rep. 2013; 3:3113.</mixed-citation></ref>
<ref id="R45"><label>45</label><mixed-citation>Connor KM, San Giovanni JP, Lofqvist C, Aderman International Journal of Medical and All Body Health Research www.allmedicaljournal.com CM, Chen J, Higuchi A, et al. Increased dietary intake of Omega3 polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med. 2007; 13:868-73.</mixed-citation></ref>
<ref id="R46"><label>46</label><mixed-citation>Hesselink JM, Chiosi F, Costagliola C. Resolvins and alamides: Lipid autacoids in ophthalmology-what promise do they hold? Drug Des Dev Ther. 2016; 10:3133-41.</mixed-citation></ref>
<ref id="R47"><label>47</label><mixed-citation>Nordgren TM, Anderson Berry A, Van Ormer M, Zoucha S, Elliott E, Johnson R, et al. Omega3 fatty acids Supplementation, pro resolving mediators and Clinical outcomes in maternal infant pairs. Nutrients. 2019; 11:98.</mixed-citation></ref>
<ref id="R48"><label>48</label><mixed-citation>Aung MT, Yu Y, Ferguson KK, Cantonwine DE, Zeng L, McElrath TF, et al. Prediction and associations of preterm birth and its subtypes with eicosanoid enzymatic pathways and inflammatory markers. Sci Rep. 2019; 9:17049.</mixed-citation></ref>
<ref id="R49"><label>49</label><mixed-citation>Perucci LO, de Castro Pinto KM, da Silva SPG, Lage EM, Teixra PG, Barbosa AS, et al. longitudinal assessment of leukotrieneB4,lipoxin A4 and resolvin D1 Plasma levels with risk factors for preeclampsia. Clin Bio-chem. 2021; 98:24-8.</mixed-citation></ref>
<ref id="R50"><label>50</label><mixed-citation>Titos E, Rius B, Lopez Vicario C, Alcarez Quiles J, Garcia Alonso V, Lopategi A, et al. Signaling and immunoresolving actions of resolvin D1 in inflammed visceral adipose tissue. J Immunol. 2016; 197:3360-70.</mixed-citation></ref>
<ref id="R51"><label>51</label><mixed-citation>Schwab JM, Chiang N, Arita M, Serhan CN. ResolvinE1 and protectin D1 activate inflammation Resolution programmes. Nature. 2007; 447:869-74.</mixed-citation></ref>
<ref id="R52"><label>52</label><mixed-citation>Pal A, Cowdy KM, Oestreich KJ, Beck M, Shakh SR. Obesity driven deficiencies of Specialized proresolving mediators may drive adverse outcomes during SARS-CoV2 infection. Front Immunol. 2020; 11:199.</mixed-citation></ref>
<ref id="R53"><label>53</label><mixed-citation>Alam I, Ng TF, Larbi A. Does inflammation determine whether Obesity is metabolically healthy or unhealthy? The aging perspective. Mediat Inflamm, 2012, 456456.</mixed-citation></ref>
<ref id="R54"><label>54</label><mixed-citation>Claria I, Dalli J, Yacoubian S, Gao F, Serhan CN. Resolvin D1 and resolvin D2govern local inflammatory tone in obese fat. J Immunol. 2012; 189:2597-2605.</mixed-citation></ref>
<ref id="R55"><label>55</label><mixed-citation>Rius B, Titos E, Moran Salvador E, Lopez Vicario C, Garcia Alonso V, Gonzalez-Periz A, et al. ResolvinD1 primes the Resolution process initiated bycalorie restriction in Obesity induced Steatohepatitis. FASEB J. 2014; 28:836-48.</mixed-citation></ref>
<ref id="R56"><label>56</label><mixed-citation>Neuhoer A, Zeyda M, Mascher D, Itariu BK, Murano I, Leitner L, et al. Impaired local production of pro resolving lipid mediators in Obesity and 17HDHA as a potential treatment for Obesityassociated inflammation. Diabetes. 2012; 62:601-5.</mixed-citation></ref>
<ref id="R57"><label>57</label><mixed-citation>Pascoal LB, Bombassaro B, Ramalho AF, Coope A, Moura RF, Correa DaSilva F, et al. Resolvin RvD2reduces hypothalamic inflammation and rescues mice from diet induced obesity. J Neuroinflammation. 2017; 14:5.</mixed-citation></ref>
<ref id="R58"><label>58</label><mixed-citation>Menon R, Richardson LS, Lappas MF, et al. Membrane architecture, aging and inflammation in pregnancy and parturition. Placenta. 2019; 79:40-5.</mixed-citation></ref>
<ref id="R59"><label>59</label><mixed-citation>Levine LD, Holland TL, Kim K, Sjaarda LA, Mumford SJ, Schisterman EF. The role of aspirin and inflammation on reproduction. The EAG eR trial. Can J Physiol Pharmacol. 2019; 97:187-92.</mixed-citation></ref>
<ref id="R60"><label>60</label><mixed-citation>Shafiq M, Mathad JS, Naik S, Alexander M, Yadana S, Araujo-Pereira M, et al. Association of Maternal inflammation during pregnancy with birth outcomes and infants growth among women with and without HIV in India. JAMA Netw Open. 2021; 4:e2140584.</mixed-citation></ref>
<ref id="R61"><label>61</label><mixed-citation>Han VX, Patel S, Jones HF, Nielse TC, Mohammed SS, Hofer MJ, et al. Maternal acute and chronic inflammation in pregnancyis associated with common neurodevelopmental disorders: a systematic review. Trans Psychiatry. 2021; 11:71.</mixed-citation></ref>
<ref id="R62"><label>62</label><mixed-citation>Izquierdo AG, Crujeiras AB, Casaneuva EE, Carreira MC. Leptin Obesity and leptin resistance:where are we 25 years later? Nutrients. 2019; 11:2704.</mixed-citation></ref>
<ref id="R63"><label>63</label><mixed-citation>Moynihan AT, Hehir MP, Glavey SV, Smith TJ, Morrison JJ. Inhibitory effects of leptin on human uterine contractility. Am JObstet Gynaecol. 2006; 195:504-9.</mixed-citation></ref>
<ref id="R64"><label>64</label><mixed-citation>Morshedzadeh N, Saedisomoelia A, Djalali M, Eshraghian MR, Hantoushzadeh S, Mahmoudi M. resolvin D1 impacts on insulin resistance in women with Polycystic ovary syndrome and healthy women. Diabetes Metab Syndr. 2019; 13:660-4.</mixed-citation></ref>
<ref id="R65"><label>65</label><mixed-citation>White PJ, Arita M, Taguchi R, Kang JX, Marette A. Transgenic restoration of long chain n3 fatty acids in insulin target tissues improves resolution capacity and alleviates Obesity linked inflammation and insulin resistance in high fat fed mice. Diabetes. 2010; 59:3066-73.</mixed-citation></ref>
<ref id="R66"><label>66</label><mixed-citation>Echeverria F, Valenzuela R, Espinosa A, Bustamante A, Alvarez D, Gonzalez-Mana D, et al. Reduction of high fat induced liver proinflammatory state by eicosapentaenoic acid plus hydroxyl sterol supplementation: involvement of resolvinRvE1/ E2 and RvD1/2. J Nutr Biochem. 2019; 63:35-43.</mixed-citation></ref>
<ref id="R67"><label>67</label><mixed-citation>Lopez Vicario C, Titos E, Walker ME, Alcarez Quiles J, Casulleras M, Duran Guell M, et al. Leukocyte from Obese individuals exhibit an impaired SPMsignature. FASEB J. 2019; 33:7072-83.</mixed-citation></ref>
<ref id="R68"><label>68</label><mixed-citation>Bashir S, Sharma Y, Jairajpuri D, Rashid F, Nematullah M, Khan F. Alterations of adipose tissue immune cell milieu towards suppression of inflammation in high fat fed micebyflaxweed supplementation. PLo SONE. 2019; 14:e0223070.</mixed-citation></ref>
<ref id="R69"><label>69</label><mixed-citation>Kosaraju R, Guesdon W, Crouch MJ, Teague HL, Sullivan EM, Karlsson EA, et al. B cell activity is impaired in human and mouse Obesity and is responsive to essential fatty acid upon murinei influenza infection. J Immunol. 2017; 198:4738-52.</mixed-citation></ref>
<ref id="R70"><label>70</label><mixed-citation>Petrakis D, Margina D, Tsarouhas K, Tekos F, Stan M, Nikitovic D, et al. Obesity-a risk factorfor increased COVID19 Prevalence, severity and lethality (review). Mol Med Rep. 2020; 22:9-19.</mixed-citation></ref>
<ref id="R71"><label>71</label><mixed-citation>Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. LICORN and the Lille COVID19 and Obesity study group. High Prevalence of Obesity severe respiratory distress syndrome Coronavirus 2 (SARS-CoV2) requiring invasive mechanical ventilation. Obesity. 2020; 28:1195-9.</mixed-citation></ref>
<ref id="R72"><label>72</label><mixed-citation>Liu M, He P, Liu HG, Wang XJ, Li FJ, Chen S, et al. Clinical characteristics of 30 medical workers infected with new Coronavirus Pneumonia. Zhongua Jie He He Hu Xi Za Zhi. 2020; 43:E016.</mixed-citation></ref>
<ref id="R73"><label>73</label><mixed-citation>Peng YD, Meng K,Guan HQ, Leng L, Zhu RR, Wang BY, et al. Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019n CoV. Zhongua Jie He He Hu Xi Za Zhi. 2020; 48:450-5.</mixed-citation></ref>
<ref id="R74"><label>74</label><mixed-citation>Lighter J, Phillips M, Hochman S, Sterling S, Jiohnson International Journal of Medical and All Body Health Research www.allmedicaljournal.com D, Francois F, et al. Obesity in in patients younger than 60years isa a risk factor for COVID19 hospital admission. Clin Infect Dis. 2020; 71:896-7.</mixed-citation></ref>
<ref id="R75"><label>75</label><mixed-citation>Costela-Ruiz VJ, Ilescas Montes R, Puerta Puerta JM, Ruis C, Melguizo Rodriques-L, et al. SARS-CoV2 infection:the role of cytokines in COVID19 disease. Cytokine Growth Factor Rev. 2020; 54:62-75.</mixed-citation></ref>
<ref id="R76"><label>76</label><mixed-citation>Neuzil KM, Reed GW, Mitchell EF, Simonsen L, Griffin MR. Impact of influenza infection on acute cardiopulmonary hospitalization. Am J Epidemiol 1998; 148:1094-1102.</mixed-citation></ref>
<ref id="R77"><label>77</label><mixed-citation>Kraus TA, Engel SM, Sperling RS, Kekkerman L, Lo Y, Wallenstein S, et al. Characteristizing the pregnancy immune phenotype: results of the viral immunity and pregnancy(VIP). J Clin Immunol. 2012;32:300-11.</mixed-citation></ref>
<ref id="R78"><label>78</label><mixed-citation>Wegmann TG, Lin H, Guilbert L, Mosmann TR. bidirectionalcytokines in the Maternal-Fetal relationship? is successful pregnancy aTh2 phenomenon. Immunol Today. 1993; 14:353-6.</mixed-citation></ref>
<ref id="R79"><label>79</label><mixed-citation>Klein SL, Passaretti C, Anker M, Olukoya A, Pekosz A. The Impact of sex, gender and pregnancy on 2009 H1N1. Biol Sex Differ. 2010; 1:5.</mixed-citation></ref>
<ref id="R80"><label>80</label><mixed-citation>Stockman LJ, Lowther SA, Coy K, Saw J, Parashar UD. SARS during pregnancy, United States. Emeg Infect Dis. 2004; 10:1689-90.</mixed-citation></ref>
<ref id="R81"><label>81</label><mixed-citation>Khalil A, Kalafat E, Benliogl CO, Brien P, Morris E, Draycott T, et al. SARS-CoV2 infection inpregnanc:a systematic review and meta-analysis of Clinical features and pregnancy outcomes. E Clinical Medicine. 2020; 25:100446.</mixed-citation></ref>
<ref id="R82"><label>82</label><mixed-citation>Panagiotakopoulos L, Myers TR, Gee J, Lipkind HS, Kjarbanda EO, Ryan DS, et al. SARS-CoV2 infection among hospitalized patients: reasons for admission and pregnancy characteristics-eight US health care centres, 1march-may302020.MMWR Morb Mort Wkly Rep. 2020; 69:1355-59.</mixed-citation></ref>
<ref id="R83"><label>83</label><mixed-citation>Lapolla A, Dalfra MG, Burlina S. Vaccination against COVID19 infection: the need for evidence for diabetic and obese pregnant women. Acta Diabetol 2021; 58:1581-5.</mixed-citation></ref>
<ref id="R84"><label>84</label><mixed-citation>Nordgren TM, Lyden E, Anderson Berry A, Hanson C. Omega3 fatty acids intake of pregnant women and women of childbearing age in the United States: potential for deficiency? Nutrients. 2017; 9:197.</mixed-citation></ref>
<ref id="R85"><label>85</label><mixed-citation>Jandacek RJ. Linoleic acid: A nutritional quandary. Healthcare. 2017; 5:25.</mixed-citation></ref>
<ref id="R86"><label>86</label><mixed-citation>Marchix J, Catherine D, Duby C, Monthean Bpolier N, Boisel F, Pedrono F, et al. Interactive effects of Maternal and weaning high Linoleic acid intake on hepatic lipid metabolism, oxylipins profile and hepatic steatosis in offspring. J Nutr J Biochem. 2020; 75:108241.</mixed-citation></ref>
<ref id="R87"><label>87</label><mixed-citation>Suratt BT, Ubags NDJ, Rastogi D, Tantisira KG, Marsland BJ, Petrache J, et al. Allergy, Immunology and inflammation assembly. An Official American Thoracic Society Workshop report: Obesity and metabolism: an emerging Frontier in lung Health and disease. Ann Am Thorac Soc. 2017; 14:1050-9.</mixed-citation></ref>
<ref id="R88"><label>88</label><mixed-citation>Souza PR, Marques RM, Gomez EA, Colas RA, DeMatties R, Zak A, et al. Enriched marine oil Supplements increase peripheral blood Specialized proresolving mediators Concentration and Reprogram host immune responses:a randomized, double blind, placebo controlled study. Circ Res. 2020; 126:75-90.</mixed-citation></ref>
<ref id="R89"><label>89</label><mixed-citation>Quiros M, Feier D, Birki D, Agarwal R, Zhou DW, Garcia AJ, et al. Resolvin E1 is a prorepair molecule that promotes intestinal epithelial wound healing. Proc NatlAcad Sci USA. 2020; 117:9477-82.</mixed-citation></ref>
<ref id="R90"><label>90</label><mixed-citation>Pal A, Al Shaeer AE, Guesdon W, Torres MJ, Armstrong M, et al. Resolvin E1, derived from eicosapentaenoic acid prevents hyperinsulinemia and hyperglycemia in a host genetic manner. FASEB J. 2020; 34:10640-56.</mixed-citation></ref>
<ref id="R91"><label>91</label><mixed-citation>Fanos V, Atzori L, Makare nko K, Melis GB, Ferrazi E. Metabolomics application in Maternal-Fetal medicine. Biomed Res Int. 2013; 2013:720514.</mixed-citation></ref>
<ref id="R92"><label>92</label><mixed-citation>Fanos V, Antonucci R, Barberini L, Noto A. Clinical application of metabolomics in neonatology. J Maternal Fetal Neonatal Med. 2012; 25(Suppl 1):104-9.</mixed-citation></ref>
</ref-list></back>
</article>